Sort
17,288 grants matching “multiple sclerosis”
Regulation of T Cell Extravasation and Activation by Ena/Vasp Proteins
$396,250Jordan Jacobelli · National Jewish Health · R01 · FY2017 · AI
Mechanisms of activity-dependent myelination in the visual system
$396,250Tara Maria Desilva · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · EY
Mechanisms of activity-dependent myelination in the visual system
$396,250Tara Maria Desilva · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · EY
Regulation of T Cell Extravasation and Activation by Ena/Vasp Proteins
$396,250Jordan Jacobelli · National Jewish Health · R01 · FY2019 · AI
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
$396,200Michael Levy · Massachusetts General Hospital · R01 · FY2021 · AI
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
$396,200Michael Levy · Massachusetts General Hospital · R01 · FY2022 · AI
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica
$396,200Michael Levy · Massachusetts General Hospital · R01 · FY2020 · AI
Pathways of HIV neurodegeneration and dimethyl fumarate (DMF/MMF) neuroprotection
$395,964Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2012 · MH
Pathogenesis of Myelin Protein Zero Neuropathies in Transgenic Mice
$395,942Lawrence Wrabetz · State University Of New York At Buffalo · R56 · FY2016 · NS
The role of mTOR signaling in oligodendrocyte differentiation and CNS myelination
$395,917Wendy B Macklin · University Of Colorado Denver · R37 · FY2018 · NS
HLA-DQ Sequencing Studies in Narcolepsy/Hypocretin Deficiency
$395,800Emmanuel J Mignot · Stanford University · U01 · FY2010 · NS
Development of a tumor-retentive immunostimulant as adjunct therapy for solid tumor cancers
$395,595Marcus Laird Forrest · Kinimmune, Inc. · R41 · FY2022 · CA
The Codon Bias-Basis for Familial Dysautonomia
$395,533Lynn D George · Montana State University -Billings · R15 · FY2018 · NS
Role of CD13 and its activators in vascular inflammation
$395,422Linda H Shapiro · University Of Connecticut Sch Of Med/Dnt · P01 · FY2011 · HL
MEMORY T CELLS IN EAE
$395,256Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2008 · AI
MEMORY T CELLS IN EAE
$395,256Samia J. Khoury · Brigham And Women'S Hospital · R01 · FY2009 · AI
Cortical mechanisms of disease progression in early multiple sclerosis
$395,240Caterina Mainero · Massachusetts General Hospital · R01 · FY2013 · NS
Neuro-Immune Mechanisms in Brain Plasticity and Aging
$395,231Mark Mattson · National Institute On Aging · ZIA · FY2013 · AG
Elucidating mechanisms involved in Lamin B1 mediated demyelination
$395,197Quasar S Padiath · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · NS
Pericyte-Macrophage Interactions Maintain CNS Immune Tolerance
$395,182Anthony J Filiano · Duke University · R01 · FY2021 · NS
Neuroprotective role of OGR1 in brain ischemia
$395,141Xiangming Zha · University Of Missouri Kansas City · R01 · FY2022 · NS
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Crohn's disease
$395,119Kenneth Schultz · Trethera Corporation · R41 · FY2023 · DK
Functional Invitro CNS and PNS Myelination Model
$395,027Stephen Lambert · University Of Central Florida · R01 · FY2013 · EB
Endothelial monoamine neurotransmitter metabolism at the blood-brain barrier
$395,000Roeben Munji · University Of California, San Diego · R01 · FY2024 · MH
Transplantation of ESC-derived thymic epithelial progenitors expressing autoantigen(s) ameliorating experimental autoimmune encephalomyelitis
$395,000Laijun Lai · University Of Connecticut Storrs · R01 · FY2020 · AI